New ADHD drug for kids shows promise in 14-Hour classroom study
NCT ID NCT05924594
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new medication (CTx-1301) for children aged 6 to 12 with ADHD. The goal is to see if it helps control symptoms like inattention and hyperactivity over a full school day. Children will take the drug or a placebo and be observed in a lab classroom for 14 hours. The study is currently on hold.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADHD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Accel Research Sites
Maitland, Florida, 32751, United States
-
Center for Psychiatry & Behavioral Medicine
Las Vegas, Nevada, 89128, United States
-
Coastal Carolina Research Center
North Charleston, South Carolina, 29405, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a gentle massage at bedtime help kids with ADHD sleep?
- Do weighted blankets unlock better sleep for kids with ADHD?
- Smartphone app may boost parenting skills for child outbursts
- Can a Once-Daily pill tame ADHD and emotional storms?
- Could a phone app help parents of kids with special needs thrive?
- Could a Self-Help guide transform parenting stress for families of kids with NDD?